Metoprolol
Prescription ·Exploratory record · not publication-reviewed ·Updated July 13, 2026
Metoprolol is a cardioselective beta-1 blocker available in immediate-release (tartrate) and extended-release (succinate) formulations. The MERIT-HF trial demonstrated significant mortality reduction in heart failure with the succinate formulation. It is widely used for hypertension, angina, heart failure, and post-MI management.
Exploratory record, not a reviewed medical publication.
See the editorial and medical-review policies for the publication gate.
This generated database record has not completed a claim-level review by a qualified human medical reviewer. Bibliography links and evidence labels are not approval. The page remains available for reference and is excluded from search indexing.
What the research says.
A quick, data-only summary. The full evidence, dosing, and sources are below.
Metoprolol is a cardioselective beta-1 blocker available in immediate-release (tartrate) and extended-release (succinate) formulations. NutriStack rates the supporting evidence as strong. Common adult dosing is Tartrate: 25–200 mg twice daily; Succinate: 25–200 mg once daily (as prescribed by your physician), though a prescriber sets the actual dose. With long-term use it can deplete coq10. This profile indexes 12 sources.
The bottom line
Evidence rating strong. Most-documented uses: reduces all-cause mortality in heart failure (merit-hf), effective blood pressure and heart rate control, reduces angina frequency and severity. 12 sources indexed (2003–2025), with 0 interaction records on file.
How it works, mechanistically.
Core mechanism
Selectively blocks beta-1 adrenergic receptors in cardiac tissue at therapeutic doses. Reduces heart rate, myocardial contractility, and cardiac output. Decreases renin release from the kidneys. Reduces myocardial oxygen demand. At higher doses, some beta-2 blocking activity may occur.6,7
Dosing & protocol.
Tartrate should be taken with or immediately following meals to enhance absorption; succinate extended-release can be taken with or without food
What it depletes.
Nutrients this medication can lower over time, and what to replace.
CoQ10
MildChronic beta-blocker therapy has been associated with lower tissue CoQ10 status and reduced mitochondrial electron transport support.
Full safety detail.
Side effects
- Bradycardia
- Fatigue and tiredness
- Dizziness
- Depression
- Cold extremities
- Gastrointestinal upset
- Bronchospasm (at higher doses, less beta-1 selective)
- Sexual dysfunction
Sources, by evidence tier.
Numbered references. Citations throughout the page link here.
Meta-analyses & systematic reviews
6- 1Metoprolol vs diltiazem for atrial fibrillation with rapid ventricular rate: Systematic review and meta-analysis of adverse eventsPMIDHintze TD, Downing JV, Acquisto NM, Downton Mslis K et al. · The American Journal of Emergency Medicine · 2025
Metoprolol and diltiazem showed similar efficacy for ventricular rate control in atrial fibrillation, but metoprolol had a different adverse event profile with more hypotension events reported
- 2A Systematic Review of Weight-Based Metoprolol for Acute Atrial Fibrillation with Rapid Ventricular RatePMIDBurum A, Carino J, McBeth M et al. · Emergency medicine international · 2023
Burum A, Carino J, McBeth M et al.. A Systematic Review of Weight-Based Metoprolol for Acute Atrial Fibrillation with Rapid Ventricular Rate. Emergency medicine international. 2023
- 3Metoprolol or Verapamil in the Management of Patients With Hypertrophic Cardiomyopathy: A Systematic ReviewPMIDTaha M, Dahat P, Toriola S et al. · Cureus · 2023
Taha M, Dahat P, Toriola S et al.. Metoprolol or Verapamil in the Management of Patients With Hypertrophic Cardiomyopathy: A Systematic Review. Cureus. 2023
- 4Intravenous diltiazem versus metoprolol for atrial fibrillation with rapid ventricular rate: A meta-analysisPMIDLan Q, Wu F, Han B et al. · The American journal of emergency medicine · 2022
Lan Q, Wu F, Han B et al.. Intravenous diltiazem versus metoprolol for atrial fibrillation with rapid ventricular rate: A meta-analysis. The American journal of emergency medicine. 2022
- 5CYP2D6 polymorphism and its impact on the clinical response to metoprolol: A systematic review and meta-analysisPMIDMeloche M, Khazaka M, Kassem I et al. · British journal of clinical pharmacology · 2020
Meloche M, Khazaka M, Kassem I et al.. CYP2D6 polymorphism and its impact on the clinical response to metoprolol: A systematic review and meta-analysis. British journal of clinical pharmacology. 2020
- 6Metoprolol for prophylaxis of postoperative atrial fibrillation in cardiac surgery patients: systematic review and meta-analysisPMIDNorhayati MN, Shaiful Bahari I, Zaharah S et al. · BMJ open · 2020
Norhayati MN, Shaiful Bahari I, Zaharah S et al.. Metoprolol for prophylaxis of postoperative atrial fibrillation in cardiac surgery patients: systematic review and meta-analysis. BMJ open. 2020
Randomized controlled trials
1- 7Comparison of carvedilol and metoprolol on clinical outcomes in patients with chronic heart failure in the Carvedilol Or Metoprolol European Trial (COMET): randomised controlled trialPMIDPoole-Wilson PA, Swedberg K, Cleland JG, Di Lenarda A et al. · Lancet · 2003
Carvedilol (25mg bid) showed superior all-cause mortality reduction compared to immediate-release metoprolol tartrate (50mg bid) in chronic heart failure, highlighting the importance of beta-blocker selection and dosing
Reference material
5- 8MERIT-HF Study Group. Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF). Lancet. 1999.Source linkedPMID
- 9Hjalmarson A et al. Effects of controlled-release metoprolol on total mortality, hospitalizations, and well-being in patients with heart failure (MERIT-HF). JAMA. 2000.Source linkedPMID
- 10Popat A et al. Impact of antihypertensive treatment on cardiovascular event reduction in patients with asymptomatic carotid artery stenosis: a systematic review and meta-analysis. Pan Afr Med J. 2025.Source linkedPMID
- 11Zamir A, Hussain I, Ur Rehman A et al.. Clinical Pharmacokinetics of Metoprolol: A Systematic Review. Clinical pharmacokinetics. 2022Source linkedPMID
- 12Dybro AM, Rasmussen TB, Nielsen RR et al.. Randomized Trial of Metoprolol in Patients With Obstructive Hypertrophic Cardiomyopathy. Journal of the American College of Cardiology. 2021Source linkedPMID
Common questions.
Quick answers about Metoprolol, drawn from the data on this page.
What is Metoprolol?
Metoprolol is a cardioselective beta-1 blocker available in immediate-release (tartrate) and extended-release (succinate) formulations. The MERIT-HF trial demonstrated significant mortality reduction in heart failure with the succinate formulation. It is widely used for hypertension, angina, heart failure, and post-MI management.
What is Metoprolol used for?
Commonly cited benefits of Metoprolol include: Reduces all-cause mortality in heart failure (MERIT-HF); Effective blood pressure and heart rate control; Reduces angina frequency and severity; Improves survival post-myocardial infarction. NutriStack rates the overall evidence as strong.
What is a typical dose of Metoprolol?
A typical adult dose of Metoprolol is Tartrate: 25–200 mg twice daily; Succinate: 25–200 mg once daily (as prescribed by your physician). The commonly recommended form is Oral tablet (tartrate for immediate-release; succinate for extended-release). These are general ranges, not personalized advice; confirm the right dose with a clinician.
What are the side effects of Metoprolol?
Reported side effects include bradycardia, fatigue and tiredness, dizziness, depression, cold extremities, gastrointestinal upset. This is educational information; check with a healthcare professional before use.
How strong is the evidence for Metoprolol?
NutriStack rates this as Strong, meaning multiple high-quality meta-analyses or systematic reviews converge on the same finding. Full tier criteria are at https://nutristackapp.com/methodology/evidence-tiers.
Use this with your stack
Metoprolol in NutriStack.
Add it to your stack, see how it interacts with everything else you take, and get a Stack Score that updates the moment it does.